These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21700544)

  • 1. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
    Bel B; Lorton MH; Darut-Jouve A; Vabres P
    Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
    [No Abstract]   [Full Text] [Related]  

  • 2. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 4. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
    Ben-Josef E
    Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
    Mayer RJ
    J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
    [No Abstract]   [Full Text] [Related]  

  • 6. Capecitabine-induced inflammation of actinic keratosis: case report and literature review.
    Stanciu M; Aubut N; Gagné E; Thibeault MM
    J Cutan Med Surg; 2012; 16(5):298-9. PubMed ID: 22971302
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
    Porschen R
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma.
    Carstens H; Albertsson M
    Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine in the treatment of colorectal cancer.
    O'Neill VJ; Cassidy J
    Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
    Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine: an overview of the side effects and their management.
    Saif MW; Katirtzoglou NA; Syrigos KN
    Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine in carcinoma of the pancreas.
    Smith DB; Neoptolemos JP
    Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine.
    Schellens JH
    Oncologist; 2007 Feb; 12(2):152-5. PubMed ID: 17296810
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine-induced terminal ileitis.
    Al-Gahmi AM; Kerr IG; Zekri JM; Zagnoon AA
    Ann Saudi Med; 2012; 32(6):661-2. PubMed ID: 23396034
    [No Abstract]   [Full Text] [Related]  

  • 15. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
    Beach DF; Somer R
    J Clin Oncol; 2011 May; 29(14):e397-401. PubMed ID: 21357787
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of capecitabine in the combined-modality therapy for rectal cancer.
    Liauw SL; Minsky BD
    Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.
    Ramani VS; Sun Myint A; Montazeri A; Wong H
    Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.